Rheumatology

JIA

Questions discussed in this category

What is the risk of uveitis flare in patients with JIA and uveitis, who are in remission, when tapering medications?

1 Answer available

Papers discussed in this category

Trials, 2020 Oct 27

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial.

Related Topics in Rheumatology